Prognostic Biomarkers of Systemic Inflammation in Non-Small Cell Lung Cancer: A Narrative Review of Challenges and Opportunities
Simple Summary Non-small cell lung cancer (NSCLC) is a common diagnosis from which
many patients die. Blood tests reflecting systemic inflammation are routinely collected in the …
many patients die. Blood tests reflecting systemic inflammation are routinely collected in the …
Association of the Scottish inflammatory prognostic score with treatment-related adverse events and prognosis in esophageal cancer receiving neoadjuvant …
Q Zhao, L Wang, X Yang, J Feng, Q Chen - Frontiers in Immunology, 2024 - frontiersin.org
Background To investigate the relationship between the Scottish inflammatory prognostic
score (SIPS), treatment-related adverse events (TRAEs), and prognostication in patients with …
score (SIPS), treatment-related adverse events (TRAEs), and prognostication in patients with …
Prognostic importance of the Scottish inflammatory prognostic score in patients with hepatocellular carcinoma after hepatectomy: a retrospective cohort study
S Shen, X Qiu, C Yang, J Li, Y Peng, Z Wen, H Luo… - BMC cancer, 2024 - Springer
Background The Scottish Inflammatory Prognostic Score (SIPS), an innovative scoring
system, has emerged as a promising biomarker for predicting patient outcomes following …
system, has emerged as a promising biomarker for predicting patient outcomes following …
A traffic light approach for treatment and supportive care stratification in lung cancer
I Phillips, L Nottelmann, M Stares - Current Opinion in Supportive …, 2024 - journals.lww.com
Current Opinion in Supportive and Palliative Care Log in or Register Subscribe to journalSubscribe
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …
Get new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle …
Associations between systemic inflammatory biomarkers and metabolic dysfunction associated steatotic liver disease: a cross-sectional study of NHANES 2017–2020
X Qiu, S Shen, N Jiang, Y Feng, G Yang, D Lu - BMC gastroenterology, 2025 - Springer
Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a primary
cause of chronic liver disease, with potential progression to cirrhosis and hepatocellular …
cause of chronic liver disease, with potential progression to cirrhosis and hepatocellular …